Results 201 to 206 of about 910,008 (206)

Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours

The Lancet Oncology, 2020
openaire   +3 more sources

A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study

Case Medical Research, 2019
openaire   +1 more source

Prevalence and detection methodology for preliminary exploration of NTRK fusion in gastric cancer from a single-center retrospective cohort.

Human Pathology
K. Dong, Lisha Yin, Yu Wang, Ling Jia, X. Diao, Xiaozheng Huang, Lixin Zhou, Dongmei Lin, Yu Sun   +8 more
semanticscholar   +1 more source

210 If at first you don't succeed…switching treatments in NTRK fusion NSCLC

Lung Cancer
Deborah Scott, Tom Geldart
semanticscholar   +1 more source

687P Targeted therapy in adult BRAF-mutant and NTRK-fusion glioblastomas and comparison with NTRK-fusion pediatric high-grade gliomas

Annals of Oncology
E. Cella, M. Padovan, A. Bosio, M. Maccari, G. Cerretti, M. Caccese, M. Corrà, P. Giordano, E. Bennicelli, C. Genova, E. Franceschi, A. Dipasquale, M. Simonelli, V. Villani, S. Lonardi, A. Mastronuzzi, G. Lombardi   +16 more
openaire   +1 more source

Diagnosing NTRK fusions in lung and thyroid cancer.

Clinical advances in hematology & oncology : H&O
openaire   +1 more source